CryoTherapeutics secures €10M in a Series B extension round led by Noshaq and existing investors to develop a next-gen catheter system to treat inflamed atherosclerotic plaque.
CryoTherapeutics secures €10M in a Series B extension round led by Noshaq and existing investors to develop a next-gen catheter system to treat inflamed atherosclerotic plaque.
04/02/24, 9:36 AM
Location
awans
Money raised
€10 million
Industry
biotechnology
health care
Round Type
series b
Investors
Ged Ventures, Innomedical, Kf W, Nrw Bank, Peppermint Venture Partners, Yellowstone Holding, Noshaq
CryoTherapeutics has raised €10 million in a Series B extension round with equity and non-dilutive funding. The investment will support additional clinical evaluation of its novel technology based on innovative cryotherapy to treat inflamed atherosclerotic plaque, as well as the development of its next-generation catheter system for advanced clinical studies and early commercialisation, and the expansion of its team in Liège.